Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06145737 · ClinicalTrials.gov registry record · NA
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)
A NA study of Multiple Sclerosis and Cognitive Dysfunction, sponsored by Dartmouth-Hitchcock Medical Center.
- Active
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06145737: Active NA study of Multiple Sclerosis and Cognitive Dysfunction, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06145737 is a NA study of Multiple Sclerosis and Cognitive Dysfunction that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 11 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06145737, a NA study of Multiple Sclerosis and Cognitive Dysfunction, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with multiple sclerosis (MS). The main questions it aims to answer are: 1. Can the current HOBSCOTCH program be adapted for people with MS? 2. Will people with MS experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program? Participants will be asked to: * attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-MS sessions with a one-on-one certified HOBSCOTCH-MS coach * complete a brief clinical questionnaire about their diagnosis of MS * complete four questionnaires before and after the HOBSCOTCH-MS sessions about their quality of life and about memory and thinking processes * keep a short daily diary about their MS symptoms and use of the self-management strategies taught in the HOBSCOTCH-MS program * complete a brief Satisfaction Survey after the entire HOBSCOTCH-MS program
Primary Outcome
The Functional Assessment of Multiple Sclerosis (FAMS) is a validated self-report health-related quality-of-life instrument for people with multiple sclerosis. The FAMS consists of 44 scored (5-point Likert scale) items in six quality-of-life domains: Mobility (seven items), Symptoms (seven items), Emotional wellbeing (seven items), General contentment (seven items), Thinking/fatigue (nine items), and Family/social wellbeing (seven items). An Additional concerns subscale consists of 15 other ite
Conditions Studied
Interventions
- BEHAVIORAL HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH)
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What the registry record for NCT06145737 still lists
NCT06145737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) is the first listed.
NCT06145737 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06145737 about?
NCT06145737 is a clinical study titled "HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)". The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with multiple sclerosis (MS). The main questions it aims to answer are: 1. Can the current HOBSCOTCH program be adapted for peop...
What is the current status of trial NCT06145737?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2024-01-02. Estimated completion is 2028-01-01.
What conditions does trial NCT06145737 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Cognitive Dysfunction, Memory Disorders.
What interventions are being tested in trial NCT06145737?
The interventions under investigation include: HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06145737?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06145737 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06145737's enrollment target sits among peer trials
11 302nd of 315 higher than 12 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI